653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient | Zendy

AI Assistant Blog Pricing

653 APN401, a novel EPiC-based anti-cancer cell therapy, case report: Cbl-b silenced, autologous PBMCs induced stable disease in an appendix carcinoma patient

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.